‘We are so close to the future we want’
Age1's General Partner Alex Colville on why moonshots have a superpower that is derisking longevity investing.
Most Popular
US government backs thymus rejuvenation project with $37m ARPA-H funding
Thymus Rejuvenation project led by Thymmune Therapeutics aims to restore damaged or non-functional thymus tissue.
‘Data-driven health is going to be the biggest revolution in the history of medicine’
The Buck and Phenome Health join forces on a data-driven approach to understanding aging biology and improving human healthspan.
Researchers land $3.2m to study impact of microbiome disruption on Alzheimer’s
Researchers at the University of Alabama to investigate the effects of microbiome disruption on Alzheimer’s disease progression.
Will psychedelics produce the next longevity drug?
Dr Halland Chen on longevity medicine, mindset and the potential of psychedelics to improve human longevity.
Supplements
NMN Bio and Aster Pharmacy unite to bring antiaging supplements to UAE market
Partnership aims to set a new standard for health and wellness in the United Arab Emirates.
Editor's pick
‘We are so close to the future we want’
Age1's General Partner Alex Colville on why moonshots have a superpower that is derisking longevity investing.
ExcepGen emerges from stealth, targets genetic medicine revolution
Genetic medicine startup on a mission to “massively expand” the reach of DNA and RNA-based genetic medicines.
Mogrify boosts Series A to $46m to advance cellular reprogramming therapies
Company’s technology enables direct in vivo transdifferentiation between any source cell type and any target cell type of clinical interest.
Laverock lands £13.5m to advance gene silencing technology
British gene-silencing technology company Laverock Therapeutics has secured £13.5 million in a seed funding round.
Watch now
‘I want medical tourism to be open to everyone, forever’
BioViva's CEO Liz Parrish on de-risking regulatory systems and creating evidence-based medicine from medical tourism.
Physicians want AI tech to help dementia patients live longer
Two-thirds of UK GPs want to prescribe tech for their dementia patients to help them remain independent and live longer.
Connected technologies are changing the future of aging at home
Huong Le Dieu, Lead Product Manager of BLabs at Baracoda Daily Healthtech, on why it's time to take aging in place to the next level.
AI innovations to transform living with dementia awarded £1.9 million
Longitude Prize on Dementia champions personalized tech that to helps people living with dementia enjoy independent and fulfilled lives.
Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech
Definitive merger agreement set to accelerate robotic companion care/AI longevity tech platform to market.
